The group of patients with high CD154-postive mast cells had lower overall 5-year survival rates than the low CD154-positive group.
Approximately one-third of patients with Waldenström macroglobulinemia (WM), a subset of lymphoplasmacytic lymphoma (LPL), had malignancies and all other patients had increased mast cells (MC), an analysis of 31 untreated patients showed.
The study, published by Annals of Laboratory Medicine, sought to identify the clinical, laboratory, and bone marrow (BM) findings of patients with WM. Additionally, the researchers were assessing the effectiveness of semiquantitative immunohistochemistry (CD20, CD138, tryptase, and CD154) for the diagnosis and prognosis of WM.
“BM MC have been reported in WM patients with increasing frequency. This association could be a diagnostic feature of WM. Moreover, MC could be potential therapeutic targets in WM. CD154 (CD40 ligand), a member of the tumor necrosis factor (TNF) superfamily, has been reported to be expressed on “activated MC” as a potent inducer of malignant B-cell growth,” the authors said.
Medical records and BM studies or flow cytometric immunotyping were reviewed for 31 patients who had untreated WM. Of the 31 patients, 6 showed symptoms of hyperviscosity syndrome, while 11 patients had solid cancer and/or hematologic malignancy. The results also revealed that MC increased in all samples. Furthermore, 5 patients had chromosomal abnormalities, according to the results.
“Most patients in our study had no specific symptoms of WM but showed abnormal laboratory findings such as rouleaux formation, reversal of albumin:globulin ratio, anemia, and monoclonal gammopathy,” the authors said. “They were thought to have plasma cell myeloma. Although WM is a lymphoma, most cases involve the BM, and some cases involve the lymph nodes and other extranodal sites. In our study, only four patients were diagnosed as having WM through a lymph node biopsy, and BM involvement of WM was confirmed via a subsequent BM study; the remaining 27 patients were diagnosed as having WM through BM examination.”
The group of patients with high CD154-postive MC had lower overall 5-year survival rates than the low CD154-positive MC group.
The authors concluded that immunohistochemistry and flow cytometric immunophenotyping may be useful for diagnosing WM while increased CD154-positive MC can indicate poor prognosis.
Reference
Ahn A, Park C, Cho Y, et al. Clinical, laboratory, and bone marrow findings of 31 patients with Waldenström macroglobulinemia [published online 2020]. Ann Lab Med. doi: 10.3343/alm.2020.40.3.193
Lymphoma Research Foundation CEO on Biden’s Cancer Moonshot, Financial Toxicity
February 3rd 2022On this episode of Managed Care Cast, we speak with Meghan Gutierrez, CEO of the Lymphoma Research Foundation, about financial toxicity, how the pandemic has affected patients’ financial needs when they have cancer, health care disparities and care gaps, and more.
Listen
Keeping Patients With Cancer Out of the ED Through Dedicated Urgent Care
October 13th 2021On this episode of Managed Care Cast, we bring you an interview conducted by the editorial director of OncLive® who talks with the advance practice provider chief at Winship Cancer Institute about how having a dedicated cancer urgent care center will make cancer treatment plans seamless whil helping patients avoid exposure to infectious diseases in emergency department waiting rooms.
Listen
Review Explores Link Between Tumor Burden, CAR T-Cell Therapy Efficacy
November 17th 2023A recent review aimed to characterize the relationship between tumor burden and clinical outcomes in patients treated with chimeric antigen receptor (CAR) T-cell therapy, highlighting the potential mechanisms of high tumor burden impacting CAR T-cell failure.
Read More
High Disease Burden at Acute Leukemia Diagnosis More Common in Black Children, Study Finds
November 3rd 2023A study evaluating disparities among children with acute leukemia found that Black children are more likely to present with higher disease burden at diagnosis compared with non-Hispanic White children.
Read More